Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children

Brian Lyttle; John Gillies; Maarja Panov; Andrzej Emeryk; Claire Wixon

doi:10.1155/2003/627531

Canadian Respiratory Journal (Jan 2003)

Fluticasone Propionate, 100 µg bid, Using a Non-CFC Propellant, HFA 134a, in Asthmatic Children

Brian Lyttle,
John Gillies,
Maarja Panov,
Andrzej Emeryk,
Claire Wixon

Affiliations

Brian Lyttle: Department of Paediatrics, Children’s Hospital of Western Ontario, London, Ontario, Canada
John Gillies: Anglesea Clinic, Hamilton, New Zealand
Maarja Panov: Department of Paediatrics, Tartu University Children’s Hospital, Tartu, Estonia
Andrzej Emeryk: Department of Paediatrics, Szpital Dzieciecy, Lublin, Poland
Claire Wixon: Respiratory Clinical Development and Product Strategy, GlaxoSmithKline Research and Development, Greenford, Middlesex, UK

DOI: https://doi.org/10.1155/2003/627531
Journal volume & issue: Vol. 10, no. 2
pp. 103 – 109

Abstract

Read online

BACKGROUND: Secondary to phasing out chlorofluorocarbons (CFCs), the fluticasone propionate (FP) pressurized metered-dose inhaler has been formulated in a nonozone-depleting propellant, hydrofluoralkane (HFA) 134a.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://www.hindawi.com/journals/crj/

About the journal